Julie L. Gerberding
CIK 1628884 · EVP, Chief Patient Officer · last filed 2026-07-23
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$6.25M
Companies
4
Total Filings
40
Lifetime Open-Market Net
-$31.84M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| MCK | Director | — | $877.23 | — | $0 | 3 | 2026-07-23 |
| HilleVax, Inc. (HLVX) Delisted | Director | 0 | $2.09 | $0 | $0 | 5 | 2025-09-17 |
| CERNER Corp (CERN) Delisted | Director | 0 | $94.92 | $0 | -$569.4K | 8 | 2022-06-09 |
| MRK | EVP, Chief Patient Officer | 48,712 | $128.33 | $6.25M | -$31.27M | 24 | 2022-02-28 |
Recent Filings · Page 4 of 4
40 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2017-05-03 | MRK | Mixed | +2,014 | -$67.2K | EDGAR |
| 2017-03-06 | CERNER Corp (CERN) Delisted | Grant (A) | +4,500 | $0 | EDGAR |
| 2017-03-01 | MRK | Grant (A) | +3,707 | $244.1K | EDGAR |
| 2016-11-08 | MRK | Mixed | — | -$1.58M | EDGAR |
| 2016-05-12 | MRK | Grant (A) | — | $0 | EDGAR |
| 2016-05-09 | MRK | Mixed | +2,436 | -$84.7K | EDGAR |
| 2016-02-24 | MRK | Grant (A) | +3,377 | $171.5K | EDGAR |
| 2015-05-11 | MRK | Mixed | +7,840 | -$709.6K | EDGAR |
| 2015-05-05 | MRK | Mixed | +2,604 | -$72.7K | EDGAR |
| 2015-02-25 | MRK | Grant (A) | +2,736 | $159.5K | EDGAR |
Showing 31–40 of 40
Prev
Page 4 of 4
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.